EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC 4.0

Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial

Ana Cardoso iD, Malwina Naghibi, Eric Climent iD, Andrea Rodenes-Gavidia iD, Araceli Lamelas iD, Laura Llobregat, Juan Martínez-Blanch iD, Daniel Friedman iD, Vineetha Vijayakumar iD, Richard Day iD

Allergy · 2026-11 · 81 (11) · 3907-3919

DOI: 10.1111/all.70360 ↗

At a glance

Randomisierte kontrollierte Studie in Allergy, published online on 2026-04-28. Written by Ana Cardoso and 9 co-authors. Institution: R&D Medical Department, ADM Health & Wellness, London, UK. Major MEDLINE topics: Bifidobacterium longum, Probiotics, Rhinitis, Allergic. Cited 3 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Archer Daniels Midland, Ministerio de Ciencia, Innovación y Universidades.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Allergic rhinitis (AR) is an increasingly common chronic inflammatory condition of the nasal mucosa. While conventional anti‐allergy treatments are widely used, they can come with side effects and are not always effective. As a result, AR remains a significant concern for many millions of people worldwide, affecting quality of life and social functioning.

Objective

To investigate clinical evidence for the role of probiotics and postbiotics in reducing AR symptoms.

Methods

In this single‐centre, randomized, double‐blind, placebo‐controlled clinical trial, 72 adults aged 18–60 years with moderate–severe AR, taking first‐line medication, were studied. The primary outcome of the trial was to determine the effects of supplementation with the probiotic Bifidobacterium longum CECT 7347 (PRO) and the heat‐treated postbiotic of the same strain (POST) on symptoms associated with AR as assessed using the Combined Symptom and Medication Score (CSMS). The secondary outcomes of the study assessed the effects of the interventions over: quality of life (rhinitis quality of life questionnaire [RQLQ]), systemic immune response, local immune response, and faecal microbiota composition.

Results

Statistically significant reduction in total CSMS after 8 weeks of supplementation was observed in the POST group compared to placebo control (CON) ( p = 0.022), showing on average a 0.6 greater reduction than placebo (CI: 0.09–1.12), equivalent to a 33.15% greater reduction and exceeding the World Allergy Organization's threshold for minimal clinically significant efficacy.

Conclusion

POST intake for 8 weeks was associated with a statistically significant reduction of total CSMS compared to placebo. There was also improvement in RQLQ parameters when compared to baseline. PRO intake for 8 weeks resulted in non‐significant beneficial effects on AR‐related symptoms. Trial Registration ClinicalTrials.gov Identifier: NCT05208528

Subjects

MeSH terms (MEDLINE)

Bifidobacterium longumProbioticsRhinitis, AllergicAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultDouble-Blind MethodHot TemperatureQuality of LifeTreatment Outcome

Author keywords

allergic rhinitisgut‐respiratory axismicrobiomepostbioticsprobiotics

Authors and institutions

  • R&D Medical Department, ADM Health & Wellness, London, UK.
  • ADM, R&D Biopolis, University of Valencia Science Park (Parc Científic de la Universitat de València), Valencia, Spain.

ORCID profiles: Ana Cardoso, Eric Climent, Andrea Rodenes-Gavidia, Araceli Lamelas, Juan Martínez-Blanch, Daniel Friedman, Vineetha Vijayakumar, Richard Day

Funding

  • Archer Daniels Midland
  • Ministerio de Ciencia, Innovación y Universidades

Cite

APA

Cardoso, A., Naghibi, M., Climent, E., Rodenes-Gavidia, A., Lamelas, A., Llobregat, L., Martínez-Blanch, J., Friedman, D., Vijayakumar, V., & Day, R. (2026). Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial. Allergy, 81(11), 3907-3919. https://doi.org/10.1111/all.70360

Vancouver

Cardoso A, Naghibi M, Climent E, Rodenes-Gavidia A, Lamelas A, Llobregat L, et al. Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial. Allergy. 2026;81(11):3907-3919. doi:10.1111/all.70360

BibTeX
@article{Cardoso2026,
  author = {Cardoso, Ana and Naghibi, Malwina and Climent, Eric and Rodenes-Gavidia, Andrea and Lamelas, Araceli and Llobregat, Laura and Martínez-Blanch, Juan and Friedman, Daniel and Vijayakumar, Vineetha and Day, Richard},
  title = {Effects of Live and Heat‐Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double‐Blind, Placebo‐Controlled Trial},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {11},
  pages = {3907--3919},
  doi = {10.1111/all.70360}
}
Start for free →